Discovery Club

The Discovery Club will allow us to communicate to our community and stakeholders the excitement and innovation happening at the RI-MUHC. Your support can help our researchers change the outcome of a illness – potentially for someone you love.

Dr. Bruce Mazer

Interim Executive Director and Chief Scientific Officer, RI-MUHC

Doctors have the power to heal…
but researchers have the power to cure – Be part of the discovery!

  • Everyday, researchers at the Research Institute of the MUHC (RI-MUHC) are using science to develop better treatments, more effective drugs, and personalized therapies
  • Everyday, they are changing the way we diagnose and treat disease
  • Everyday, your support will bring us one step closer to ensuring that when someone you know or love gets sick, the MUHC will be ready to provide them with the best care for life.

The RI-MUHC bridges the gap between discovery and cure and takes research from bench to bedside. It is this type of research that can only happen in a teaching hospital like the MUHC, and the Montreal community is the first to benefit from the research discoveries that are made right here at home.

The RI-MUHC makes tomorrow’s health care possible, but in order to continue to power the research behind the diagnosis, treatment and prevention of some of the world’s most critical diseases, we need to make an investment in the future.

Help make the next research breakthrough by joining the Discovery Club today!

The Discovery Club puts you at the forefront of helping our researchers create the most effective and personalized treatments that will improve care and save more lives. Your investment of $365 annually or $30 per month will help ensure a brighter and healthier future for the mothers, fathers, sisters, brothers, and grandparents who are affected by serious complex illnesses.

For just $1 a day, you will receive:
  • Invitations to exclusive events – get to know our leading scientists and clinicians, learn more about the impact of their research, and visit their laboratories
  • Receive exciting news about recent research discoveries and be one of the first to understand the impact on healthcare in our community, and around the world
  • Recognition in our Annual Report, on our website and within the hospital and RI-MUHC

Be part of the Discovery, donate today.

Meet some of the researchers that are powering discovery at the RI-MUHC

Dr. Kaberi Dasgupta is helping improve the lives of type 2 diabetes patients

Type 2 diabetes is a serious illness that can lead to heart attacks, strokes, and blindness if left unmanaged, but Dr. Kaberi Dasgupta is working to change this outcome one step at a time. Research has shown that regular walking can lead to a 40 percent reduction in the mortality rate over the next decade for adults with type 2 diabetes. With people walking under 5,000 steps at a high risk of developing type 2 diabetes, Dr. Dasgupta’s recent research demonstrated that that physician-delivered step count prescriptions, combined with the use of a pedometer, led to a 20 per cent increase in daily steps, as well as measurable health benefits, such as lower blood sugar and lower insulin resistance.

Dr. Miguel Burnier is leading the world’s most advanced ocular pathology lab

More than 5.5 million Canadians live with a major eye disease that could cause vision loss and the prevalence of vision loss in our country is expected to increase nearly 30% in the next decade. Dr. Miguel Burnier runs the internationally renowned MUHC Ocular Pathology Lab, which strives to translate basic research findings into advanced treatment options for patients living with ocular diseases. Students from Canada and around the world train year-round at the lab’s state-of-the-art facility within the MUHC’s Research Institute. The lab’s expertise along with some of the most innovative research equipment and technology available make it the largest and one of the most successful and dynamic research facilities in the world.

Dr. Burnier’s lab is the only one conducting ocular metastasis research globally, and he and his team are working to find a cure for uveal melanoma, the most common type of ocular cancer that is mostly found in adults. Uveal melanoma has a very low survival rate and almost half of those who are diagnosed will succumb to the disease because it has the ability to spread rapidly to other organs, particularly the liver, where it is often diagnosed. The lab is working to change this outcome by developing more effective treatments while also investigating how these cancer cells spread, which may have an impact on a range of other ocular diseases.

Dr. Nitika Pant Pai is revolutionizing HIV testing for those who need it most

Dr. Nitika Pant Pai

HIV/AIDS is a global healthcare problem affecting more than 36.9 million people worldwide, and 50% of these infected individuals do not know that they are HIV positive. Developed as a result of over ten years of research, Dr. Pant Pai’s HIVsmart! app is an open access mobile phone app that facilitates HIV self-testing. It guides an individual through the process of performing their own non-invasive HIV screening test, which can detect the presence of HIV antibodies within 20 minutes and be conducted in the privacy of one’s own home. The app provides information, instructional videos, a 24 hour help line and confidential linkages to healthcare facilities and access to counsellors should they have a positive test.

Dr. Pant Pai launched the app as part of a pilot project in South Africa, and it demonstrated significant improvements in the acceptance of HIV self-testing among users. Her work is transforming health care and empowering patients to break the stigma associated with getting tested while also curbing the number of newly-diagnosed HIV cases in a cost-effective manner.

Dr. Matthias Friedrich is using next generation imaging to diagnose heart disease

Dr. Matthias Friedrich

Cardiac magnetic resonance imaging (CMR) is one of the safest imaging techniques available for evaluating and diagnosing heart disease since it does not expose a patient to any radiation. This non-invasive exam produces high resolution 3D images and its unrivalled versatility allows physicians to see key details about the heart including: shape, volume, blood flow, abnormal tissue, and oxygen.

Dr. Matthias Friedrich, an international cardiovascular imaging expert, is leading a variety of MUHC clinical research studies using CMR, and he and his team’s findings will be transformed directly into new clinical treatments for patients living with acute and chronic cardiovascular diseases. He is also collaborating with other leading cardiovascular disease imaging centres across Canada and around the world to help patients receive faster and more accurate diagnoses, which will increase the speed at which they can begin treatment.

Follow Us

LEAP has selected Centre universitaire de santé McGill - McGill University Health Centre cardiologist & Research Institute of the McGill University Health Centre researcher, Dr. Abhinav Sharma’s, MyHeart Counts Canada mobile application for their Healthy Future Accelerator. MyHeart Counts Canada’s goal is to get Canadians moving for improved cardiovascular health. Dr. Sharma’s app uses artificial-intelligence with real-time feedback and support to improve physical activity incrementally. LEAP is donating $100, 000 to support the continued development of Dr. Sharma’s app through the MUHC Foundation’s Fix Broken Hearts campaign. Watch: 📺

LEAP a choisi l'application mobile MyHeart Counts Canada du Dr Abhinav Sharma, cardiologue du CUSM et chercheur de l'IR-CUSM, pour leur accélérateur Horizons Santé. L’objectif de MyHeart Counts Canada est de faire bouger les Canadiens pour une meilleure santé cardiovasculaire. L'application mobile du Dr Sharma utilise l'intelligence artificielle avec rétroaction et l’assistance en temps réel pour améliorer progressivement l'activité physique. LEAP fait un don de 100 000 $ pour soutenir le développement continu de l'application du Dr Sharma dans le cadre de la campagne Souder les cœurs brisés de la Fondation du CUSM.
... See MoreSee Less

View on Facebook

Ce « Mardi je donne » est presque terminé! ⏰ Pour chaque femme dont la vie a été anéantie par le cancer de l’ovaire ou de l’endomètre. Pour chaque mère qui ne verra pas ses enfants grandir en raison de ces maladies. Pour chaque femme qui lutte actuellement pour sa vie, unissons-nous comme jamais auparavant. ❤️ The DOVEE Project

✨ Faites un don:

#MardiJeDonne #OsezRêverFCUSM

Giving Tuesday is nearing its end!⏱ For every woman whose life has been cut short because of ovarian or endometrial cancers. For every mother who won’t see her children grow up because of these diseases. For every woman fighting for her life right now, let’s come together like never before.


#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Let’s do this, Montreal—we’re more than halfway through Giving Tuesday and we need every one of you to help us reach our $70,000 goal. 🙌 Support Dr. Gilbert, Joanne, Lawrie and the entire The DOVEE Project's Giving Tuesday dream of stopping ovarian and endometrial cancers. Combined, more than 3,000 Canadian women die each year from these cancers—but it doesn’t have to be this way. Let’s stop these deadly killers, once and for all.

✨ Donate now:

Plus de 3 000 Canadiennes succombent chaque année à ces deux cancers, mais nous pouvons les sauver. Arrêtons ces tueurs silencieux, une fois pour toutes.

✨Faites un don:

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

À l’occasion de « Mardi je donne », votre contribution sera égalée jusqu’à concurrence de 50 000 $ grâce à la générosité d’un grand donateur anonyme! La Dre Gilbert et ses collègues Centre universitaire de santé McGill - McGill University Health Centre ont mis au point un test sécuritaire et moins invasif qui permet de dépister les cancers de l’ovaire et de l’endomètre de façon plus précoce que jamais auparavant.

✨ Faites un don:
It's Giving Tuesday, and your donation today will be doubled up to $50,000 thanks to a generous anonymous donor. Dr. Gilbert and her colleagues @ The DOVEE Project have developed a test that offers a safe, less invasive way to detect ovarian and endometrial cancers earlier than ever before. The answer for moving this test into clinical implementation? Generous Giving Tuesday supporters like you. ❤️

✨ Donate now:

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Demain, c’est la journée « Mardi je donne ». Voici un message important de Lawrie Shahbazian, une coordonnatrice du projet DOvEEgene The DOVEE Project

« Les femmes qui reçoivent un diagnostic de cancer de l’ovaire ou de l’endomètre se posent souvent cette question : ‘ J’ai pris soin de ma santé. J’ai passé les examens, les tests Pap et les mammographies. Qu’est-ce que j’aurais pu faire de plus?’ La réponse, c’est DOvEEgene. Notre test minimalement invasif fonctionne, ici et maintenant. Nous en sommes à la dernière étape de notre marathon, le passage aux essais cliniques de stade trois. En tant que jeune femme, je compte bien voir les résultats et les bienfaits de notre travail acharné de mon vivant. Avec votre aide, nous sauverons des vies.”

✨Faites un don:
... See MoreSee Less

View on Facebook